Suppression of human anti-mouse antibody response to murine monoclonal antibody L6 by deoxyspergualin: a phase I study. 1994

K Dhingra, and H Fritsche, and J L Murray, and A F LoBuglio, and M B Khazaeli, and S Kelley, and M Tepper, and D Greene, and D Booser, and A Buzdar
Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D005260 Female Females
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K Dhingra, and H Fritsche, and J L Murray, and A F LoBuglio, and M B Khazaeli, and S Kelley, and M Tepper, and D Greene, and D Booser, and A Buzdar
June 1994, Transplantation,
K Dhingra, and H Fritsche, and J L Murray, and A F LoBuglio, and M B Khazaeli, and S Kelley, and M Tepper, and D Greene, and D Booser, and A Buzdar
September 1997, Japanese journal of cancer research : Gann,
K Dhingra, and H Fritsche, and J L Murray, and A F LoBuglio, and M B Khazaeli, and S Kelley, and M Tepper, and D Greene, and D Booser, and A Buzdar
June 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
K Dhingra, and H Fritsche, and J L Murray, and A F LoBuglio, and M B Khazaeli, and S Kelley, and M Tepper, and D Greene, and D Booser, and A Buzdar
November 1994, Clinical and experimental immunology,
K Dhingra, and H Fritsche, and J L Murray, and A F LoBuglio, and M B Khazaeli, and S Kelley, and M Tepper, and D Greene, and D Booser, and A Buzdar
January 1989, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology,
K Dhingra, and H Fritsche, and J L Murray, and A F LoBuglio, and M B Khazaeli, and S Kelley, and M Tepper, and D Greene, and D Booser, and A Buzdar
May 1988, Antimicrobial agents and chemotherapy,
K Dhingra, and H Fritsche, and J L Murray, and A F LoBuglio, and M B Khazaeli, and S Kelley, and M Tepper, and D Greene, and D Booser, and A Buzdar
May 1994, Pharmaceutical research,
K Dhingra, and H Fritsche, and J L Murray, and A F LoBuglio, and M B Khazaeli, and S Kelley, and M Tepper, and D Greene, and D Booser, and A Buzdar
May 1989, Transplantation,
K Dhingra, and H Fritsche, and J L Murray, and A F LoBuglio, and M B Khazaeli, and S Kelley, and M Tepper, and D Greene, and D Booser, and A Buzdar
April 1983, Human immunology,
K Dhingra, and H Fritsche, and J L Murray, and A F LoBuglio, and M B Khazaeli, and S Kelley, and M Tepper, and D Greene, and D Booser, and A Buzdar
January 1999, Journal of Tongji Medical University = Tong ji yi ke da xue xue bao,
Copied contents to your clipboard!